"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis"

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 1, 2026

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions
Hypersensitivity Pneumonitis
Interventions
DRUG

Prednisolone

"Active Comparator: prednisolone. Oral prednisolone will be administered and tapered over 6 months, according to the following schedule\*:~0.5 mg/kg/day (not exceeding 40mg/day) x 4 weeks, 0.25 mg/kg/day (not exceeding 20mg/day) x 4 weeks, 15 mg/day x 4 weeks, 10 mg/days x 4 weeks, 5 mg/day x 10 weeks"

DRUG

Placebo

Dispersible placebo administered and tapered over 6 months according to the schedule detailed in the protocol

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER